Search

everythinglearnresearchcommunity

for

Search:↓

Public interest in skin issues changed during COVID-19, with more focus on dry skin, hair problems, and hand eczema.

Some drugs may help treat both COVID-19 and radiation injury.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

Some recovered COVID-19 patients experience skin, hair, and nail issues, suggesting they need follow-up care.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

Gender-affirming care for youth remained essential during the COVID-19 pandemic, with telemedicine playing a key role.

One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.

During the COVID-19 pandemic in Turkey, the most common skin problem for both kids and adults was acne.

SIM01 significantly reduced post-COVID symptoms and is safe.

Teletrichoscopy is a promising method for diagnosing hair disorders remotely during the COVID-19 pandemic.

Early treatment improved COVID-19 outcomes, and spironolactone helped reduce risks in females with high androgen levels.

The Covishield COVID-19 vaccine caused skin-related side effects in 1.23% of the people vaccinated in the study from India.

More children are showing signs of hair-pulling disorders during the COVID-19 pandemic due to stress and lack of social interaction.

AGA might indicate higher risk for severe COVID-19.

Hydroxychloroquine might help prevent COVID-19, but more research is needed.

Long-lasting COVID-19 symptoms like fatigue and breathing difficulties can persist for over 60 days, requiring ongoing care.

Some early COVID-19 mutations in patients predicted future common virus mutations.

Teledermatology was popular among young adults and women, and high-resolution photos improved service during the pandemic.

Male hormones may make COVID-19 worse, while substances that block these hormones could lessen symptoms.

Most skin reactions to COVID-19 vaccines in India were mild and not a reason to avoid vaccination.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

Long-term effects of COVID-19 can vary over time and are more likely in certain age and gender groups, while race, income, and education levels have little to no impact. Ongoing medical care is needed due to potential complications.

Psoriasis treatments don't raise severe COVID-19 risk, except for acitretin.

Many hospitalized children with COVID-19 had skin, mouth, or nail changes, with skin rashes being common.

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.